Depth‐dependent concentrations of hematopoietic stem cells in the adult skeleton: Implications for active marrow dosimetry

Journal Article · Mon Jan 30 00:00:00 EST 2017 · Medical Physics

DOI:https://doi.org/10.1002/mp.12056· OSTI ID:1400801

Geyer, Amy M. ^[1]; Schwarz, Bryan C. ^[1]; O'Reilly, Shannon E. ^[1]; Hobbs, Robert F. ^[2]; Sgouros, George ^[3]; Bolch, Wesley E. ^[1]

---

1. J Crayton Pruitt Family Department of Biomedical Engineering University of Florida Gainesville FL 32611‐6131 USA
2. Department of Radiation Oncology Johns Hopkins University School of Medicine Baltimore MD 21231 USA
3. Department of Radiology Johns Hopkins University School of Medicine Baltimore MD 21231 USA

Purpose The hematopoietically active (or red) bone marrow is the target tissue assigned in skeletal dosimetry models for assessment of stochastic effects (leukemia induction) as well as tissue reactions (marrow toxicity). Active marrow, however, is in reality a surrogate tissue region for specific cell populations, namely the hematopoietic stem and progenitor cells. Present models of active marrow dosimetry implicitly assume that these cells are uniformly localized throughout the marrow spaces of trabecular spongiosa. Data from Watchman et al. and Bourke et al., however, clearly indicate that there is a substantial spatial concentration gradient of these cells with the highest concentrations localized near the bone trabeculae surfaces. The purpose of the present study was thus to explore the dosimetric implications of these spatial gradients on active marrow dosimetry. Methods Images of several bone sites from a 45‐yr female were retagged to group active marrow voxels into 50 μm increments of marrow depth, after which electron and alpha‐particle depth‐dependent specific absorbed fractions were computed for four source tissues — active marrow, inactive marrow, bone trabeculae volumes, and bone trabeculae surfaces. Corresponding depth‐dependent S values (dose to a target tissue per decay in a source tissue) were computed and further weighted by the relative target cell concentration. These depth‐weighted radionuclide S values were systematically compared to the more traditional volume‐averaged radionuclide S values of the MIRD schema for both individual bones of the skeleton and their skeletal‐averaged quantities. Results For both beta‐emitters and alpha‐emitters localized in the active and inactive marrow, depth‐weighted S values were shown to differ from volume‐averaged S values by only a few percent, as dose gradients across the marrow tissues are nonexistent. For bone volume and bone surface sources of alpha‐emitters and lower energy beta‐emitters, when marrow dose gradients are expected, explicit consideration of target cell spatial concentration gradients are shown to significantly impact marrow dosimetry. Conclusions For medical isotopes currently utilized for treatment of skeletal metastases, namely ¹⁵³ Sm and ²²³ Ra, accounting for hematopoietic stem and progenitor cell concentration gradients resulted in maximum percent differences to reference skeletal‐averaged S values of ~21% and 55%, respectively.

• Sponsoring Organization: USDOE
• OSTI ID: 1400801
• Journal Information: Medical Physics, Journal Name: Medical Physics Vol. 44 Journal Issue: 2; ISSN 0094-2405
• Publisher: Wiley Blackwell (John Wiley & Sons)
• Country of Publication: United States
• Language: English